DaShenLin Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 4/6
DaShenLin Pharmaceutical Group has a total shareholder equity of CN¥8.5B and total debt of CN¥3.8B, which brings its debt-to-equity ratio to 45.3%. Its total assets and total liabilities are CN¥25.4B and CN¥16.9B respectively. DaShenLin Pharmaceutical Group's EBIT is CN¥1.7B making its interest coverage ratio 11.2. It has cash and short-term investments of CN¥5.4B.
Key information
45.3%
Debt to equity ratio
CN¥3.83b
Debt
Interest coverage ratio | 11.2x |
Cash | CN¥5.40b |
Equity | CN¥8.46b |
Total liabilities | CN¥16.91b |
Total assets | CN¥25.37b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 603233's short term assets (CN¥11.8B) do not cover its short term liabilities (CN¥12.1B).
Long Term Liabilities: 603233's short term assets (CN¥11.8B) exceed its long term liabilities (CN¥4.8B).
Debt to Equity History and Analysis
Debt Level: 603233 has more cash than its total debt.
Reducing Debt: 603233's debt to equity ratio has increased from 10.7% to 45.3% over the past 5 years.
Debt Coverage: 603233's debt is well covered by operating cash flow (95.2%).
Interest Coverage: 603233's interest payments on its debt are well covered by EBIT (11.2x coverage).